Literature DB >> 7691169

Activation of retinal rod cGMP-gated channels: what makes for an effective 8-substituted derivative of cGMP?

R L Brown1, R J Bert, F E Evans, J W Karpen.   

Abstract

Analogs of cGMP bearing diverse substituents at the C8 position of the guanine ring system have been shown to activate the cGMP-activated channel of retinal rods at concentrations lower than cGMP itself. In an effort to understand this behavior, we synthesized eight novel C8-substituted derivatives and tested their ability to activate channels in excised patches from salamander rod outer segments. We express the effectiveness of each analog as a ratio (in brackets) of the concentration required to open half of the channels in a patch to that required of 8-Br-cGMP, previously shown to be about 10 times more effective than cGMP. Five of the derivatives contained a thio substitution at C8: n-propylthio-cGMP [0.61], sulfoethylthio-cGMP [0.90], carboxyethylthio-cGMP [0.97], aminoethylthio-cGMP [2.8], and (trimethylamino)ethylthio-cGMP [8.5]. Three of the derivatives contained an amino substitution at C8: carboxyethylamino-cGMP [22], n-propylamino-cGMP [25], and aminoethylamino-cGMP [230]. The results indicate that thio-substitution at C8 produces more effective analogs than does amino-substitution, regardless of the chemical nature of the terminal functional group. Derivatives containing neutral and apolar tails opened channels at much lower concentrations than their positively-charged counterparts with the same C8 substituent. Analogs having negatively-charged tails were also more effective than those with positive charge but not quite as effective as those with neutral tails.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691169     DOI: 10.1021/bi00089a026

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Novel Fluorescent Cyclic Nucleotide Derivatives to Study CNG and HCN Channel Function.

Authors:  Maik Otte; Andrea Schweinitz; Marco Lelle; Susanne Thon; Uta Enke; Sezin Yüksel; Ralf Schmauder; Michele Bonus; Holger Gohlke; Klaus Benndorf
Journal:  Biophys J       Date:  2019-05-10       Impact factor: 4.033

2.  Substituted cGMP analogs can act as selective agonists of the rod photoreceptor cGMP-gated cation channel.

Authors:  J Y Wei; E D Cohen; H G Genieser; C J Barnstable
Journal:  J Mol Neurosci       Date:  1998-02       Impact factor: 3.444

Review 3.  Molecular mechanisms of cyclic nucleotide-gated channels.

Authors:  W N Zagotta
Journal:  J Bioenerg Biomembr       Date:  1996-06       Impact factor: 2.945

Review 4.  The pharmacology of cyclic nucleotide-gated channels: emerging from the darkness.

Authors:  R Lane Brown; Timothy Strassmaier; James D Brady; Jeffrey W Karpen
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

5.  Diffusion coefficient of the cyclic GMP analog 8-(fluoresceinyl)thioguanosine 3',5' cyclic monophosphate in the salamander rod outer segment.

Authors:  Y Koutalos; R L Brown; J W Karpen; K W Yau
Journal:  Biophys J       Date:  1995-11       Impact factor: 4.033

6.  Novel N7- and N1-substituted cGMP derivatives are potent activators of cyclic nucleotide-gated channels.

Authors:  Timothy Strassmaier; Jeffrey W Karpen
Journal:  J Med Chem       Date:  2007-08-01       Impact factor: 7.446

7.  Movement of gating machinery during the activation of rod cyclic nucleotide-gated channels.

Authors:  R L Brown; S D Snow; T L Haley
Journal:  Biophys J       Date:  1998-08       Impact factor: 4.033

8.  Covalent activation of retinal rod cGMP-gated channels reveals a functional heterogeneity in the ligand binding sites.

Authors:  J W Karpen; R L Brown
Journal:  J Gen Physiol       Date:  1996-02       Impact factor: 4.086

9.  Hydrophobic alkyl chains substituted to the 8-position of cyclic nucleotides enhance activation of CNG and HCN channels by an intricate enthalpy - entropy compensation.

Authors:  Maik Otte; Andrea Schweinitz; Michele Bonus; Uta Enke; Christina Schumann; Holger Gohlke; Klaus Benndorf
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.